Purchase Order 75N95024P00648

Award Date 9/19/24
Potential Completion Date 10/18/24
Potential Value $24K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment. The $149,750.00 contract is for the delivery of Lumos multiwell consumable plates to be used with Axion's proprietary Maestro multi-electrode array (MEA) system, which supports biomedical and drug development research...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $12,960.00, is for the delivery of CYTOVIEW MEA 48-WELL WHITE PLATE (BOX OF 5) by the prime contractor, Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and instruments. The contract does not have a set-aside designation and has an ultimate...
This is a $130,289 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of Axion's proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and related accessories like optical stimulation modules...
This is a $72,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc., a foreign-owned manufacturer, for the procurement of 16 boxes of 48-well and 16 boxes of 96-well Axion CytoView microelectrode array plates. The purchase order supports NCATS' Division of Preclinical Innovation's Therapeutic Development Branch and their N=1 antisense oligonucleotide (ASO)...
This federal contract award, valued at $149,845.00, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS). The contract was awarded to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized live cell analysis technologies, primarily its Maestro multi-electrode array (MEA) systems and related instrumentation and consumables. The contract does not have a set-aside designation. Axion Biosystems...
This is a $110,200.00 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is a civilian agency within the U.S. Department of Health and Human Services. The contract is for a service and maintenance agreement for an Axion Biosystems instrument, which is likely one of the company's proprietary Maestro multi-electrode array (MEA) systems or related cell analysis platforms. Axion Biosystems, Inc. is the prime contractor, and the contract...
This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of biomedical research equipment and instruments. The $728,050 firm fixed-price purchase order is for the provision of Maestro Apex system, Maestro Pro microelectrode array (MEA) platform, and related accessories to support NCATS' Helping to End Addiction Long Term (HEAL) Initiative. The equipment...
This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...
This is a $216,245 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for a Multiwell Microelectrode Array System, which is a specialized laboratory instrument used for real-time monitoring of neural and cardiac activity. The prime contractor is Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of biomedical research equipment. This contract...
This is a $152,766 firm fixed price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian federal agency, to the small business Axion Biosystems, Inc. The contract is for Axion's MaestroPro 768-channel multi-electrode array (MEA) system, neural applications software, related MEA plates, installation and training. This specialized equipment is needed to investigate how neural circuit activity changes in response to temperature variations, in order to...

This federal contract award, valued at $24,440.00, was issued by the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment. The contract is for the delivery of 10 boxes of 48-well Axion CytoView microelectrode array (MEA) plates, which are required for neurotoxicity screening assays as part of the HEAL siRNA/ASO toxicity collaborative project. This project aims to facilitate the safety approval process for antisense oligonucleotide (ASO) treatments. The award is not designated as a set-aside contract. Axion Biosystems has been a prime contractor for numerous federal agencies, including NIH, FDA, EPA, and VA, providing its proprietary Maestro MEA systems and related consumables to support biomedical and drug development research.

Generated 9/20/24, 9:12 AM